nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Epirubicin—ovarian cancer	0.147	0.214	CbGbCtD
Saxagliptin—ABCC1—Paclitaxel—ovarian cancer	0.145	0.211	CbGbCtD
Saxagliptin—ABCC1—Docetaxel—ovarian cancer	0.105	0.153	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—ovarian cancer	0.0782	0.114	CbGbCtD
Saxagliptin—CYP3A5—Paclitaxel—ovarian cancer	0.0538	0.0782	CbGbCtD
Saxagliptin—CYP3A4—Topotecan—ovarian cancer	0.0424	0.0616	CbGbCtD
Saxagliptin—CYP3A5—Docetaxel—ovarian cancer	0.0389	0.0566	CbGbCtD
Saxagliptin—CYP3A4—Vinorelbine—ovarian cancer	0.0299	0.0434	CbGbCtD
Saxagliptin—CYP3A4—Paclitaxel—ovarian cancer	0.021	0.0305	CbGbCtD
Saxagliptin—CYP3A4—Docetaxel—ovarian cancer	0.0152	0.0221	CbGbCtD
Saxagliptin—CYP3A4—Doxorubicin—ovarian cancer	0.0113	0.0164	CbGbCtD
Saxagliptin—DPP8—myometrium—ovarian cancer	0.00981	0.0712	CbGeAlD
Saxagliptin—DPP9—decidua—ovarian cancer	0.00799	0.058	CbGeAlD
Saxagliptin—DPP8—uterine cervix—ovarian cancer	0.00763	0.0554	CbGeAlD
Saxagliptin—DPP8—decidua—ovarian cancer	0.00727	0.0528	CbGeAlD
Saxagliptin—DPP8—endometrium—ovarian cancer	0.0069	0.0501	CbGeAlD
Saxagliptin—DPP9—female gonad—ovarian cancer	0.00572	0.0415	CbGeAlD
Saxagliptin—DPP8—bone marrow—ovarian cancer	0.0054	0.0392	CbGeAlD
Saxagliptin—DPP8—female gonad—ovarian cancer	0.0052	0.0378	CbGeAlD
Saxagliptin—DPP8—vagina—ovarian cancer	0.00517	0.0376	CbGeAlD
Saxagliptin—DPP9—testis—ovarian cancer	0.00507	0.0368	CbGeAlD
Saxagliptin—Lymphopenia—Chlorambucil—ovarian cancer	0.00493	0.0282	CcSEcCtD
Saxagliptin—DPP8—testis—ovarian cancer	0.00462	0.0335	CbGeAlD
Saxagliptin—SLCO4C1—endometrium—ovarian cancer	0.00437	0.0317	CbGeAlD
Saxagliptin—DPP4—embryo—ovarian cancer	0.00396	0.0288	CbGeAlD
Saxagliptin—DPP9—lymph node—ovarian cancer	0.00368	0.0267	CbGeAlD
Saxagliptin—SLCO4C1—bone marrow—ovarian cancer	0.00342	0.0248	CbGeAlD
Saxagliptin—DPP8—lymph node—ovarian cancer	0.00335	0.0243	CbGeAlD
Saxagliptin—SLCO4C1—vagina—ovarian cancer	0.00327	0.0238	CbGeAlD
Saxagliptin—DPP4—epithelium—ovarian cancer	0.00323	0.0235	CbGeAlD
Saxagliptin—Opportunistic infection—Paclitaxel—ovarian cancer	0.00321	0.0184	CcSEcCtD
Saxagliptin—DPP4—uterine cervix—ovarian cancer	0.00321	0.0233	CbGeAlD
Saxagliptin—Blood creatine phosphokinase increased—Melphalan—ovarian cancer	0.0032	0.0183	CcSEcCtD
Saxagliptin—DPP4—decidua—ovarian cancer	0.00305	0.0222	CbGeAlD
Saxagliptin—DPP4—endometrium—ovarian cancer	0.0029	0.0211	CbGeAlD
Saxagliptin—Pancreatitis acute—Paclitaxel—ovarian cancer	0.0028	0.016	CcSEcCtD
Saxagliptin—DPP4—uterus—ovarian cancer	0.00267	0.0194	CbGeAlD
Saxagliptin—Lymphopenia—Paclitaxel—ovarian cancer	0.00253	0.0145	CcSEcCtD
Saxagliptin—Thrombocytopenia—Altretamine—ovarian cancer	0.00248	0.0142	CcSEcCtD
Saxagliptin—DPP4—female reproductive system—ovarian cancer	0.0024	0.0174	CbGeAlD
Saxagliptin—ABCC1—myometrium—ovarian cancer	0.00233	0.0169	CbGeAlD
Saxagliptin—DPP4—bone marrow—ovarian cancer	0.00227	0.0165	CbGeAlD
Saxagliptin—DPP4—female gonad—ovarian cancer	0.00219	0.0159	CbGeAlD
Saxagliptin—Fatigue—Altretamine—ovarian cancer	0.00219	0.0125	CcSEcCtD
Saxagliptin—DPP4—vagina—ovarian cancer	0.00217	0.0158	CbGeAlD
Saxagliptin—Lymphopenia—Docetaxel—ovarian cancer	0.00214	0.0123	CcSEcCtD
Saxagliptin—DPP4—testis—ovarian cancer	0.00194	0.0141	CbGeAlD
Saxagliptin—Opportunistic infection—Epirubicin—ovarian cancer	0.00184	0.0105	CcSEcCtD
Saxagliptin—Asthenia—Altretamine—ovarian cancer	0.00182	0.0104	CcSEcCtD
Saxagliptin—ABCC1—uterine cervix—ovarian cancer	0.00181	0.0132	CbGeAlD
Saxagliptin—Infection—Carboplatin—ovarian cancer	0.00174	0.00996	CcSEcCtD
Saxagliptin—ABCC1—decidua—ovarian cancer	0.00173	0.0125	CbGeAlD
Saxagliptin—Opportunistic infection—Doxorubicin—ovarian cancer	0.0017	0.00972	CcSEcCtD
Saxagliptin—Dizziness—Altretamine—ovarian cancer	0.00168	0.00959	CcSEcCtD
Saxagliptin—ABCC1—endometrium—ovarian cancer	0.00164	0.0119	CbGeAlD
Saxagliptin—Vomiting—Altretamine—ovarian cancer	0.00161	0.00923	CcSEcCtD
Saxagliptin—ABCC1—uterus—ovarian cancer	0.00151	0.011	CbGeAlD
Saxagliptin—Nausea—Altretamine—ovarian cancer	0.00151	0.00862	CcSEcCtD
Saxagliptin—Lymphopenia—Epirubicin—ovarian cancer	0.00144	0.00827	CcSEcCtD
Saxagliptin—DPP4—lymph node—ovarian cancer	0.00141	0.0102	CbGeAlD
Saxagliptin—CYP3A5—uterine cervix—ovarian cancer	0.00139	0.0101	CbGeAlD
Saxagliptin—Lymphopenia—Doxorubicin—ovarian cancer	0.00134	0.00765	CcSEcCtD
Saxagliptin—Blood creatinine increased—Vinorelbine—ovarian cancer	0.00131	0.00749	CcSEcCtD
Saxagliptin—Infestation—Topotecan—ovarian cancer	0.00126	0.0072	CcSEcCtD
Saxagliptin—Infestation NOS—Topotecan—ovarian cancer	0.00126	0.0072	CcSEcCtD
Saxagliptin—ABCC1—female gonad—ovarian cancer	0.00124	0.00898	CbGeAlD
Saxagliptin—ABCC1—vagina—ovarian cancer	0.00123	0.00892	CbGeAlD
Saxagliptin—Pancreatitis—Vinorelbine—ovarian cancer	0.00118	0.00677	CcSEcCtD
Saxagliptin—ABCC1—testis—ovarian cancer	0.0011	0.00796	CbGeAlD
Saxagliptin—Infestation NOS—Vinorelbine—ovarian cancer	0.00108	0.00616	CcSEcCtD
Saxagliptin—Infestation—Vinorelbine—ovarian cancer	0.00108	0.00616	CcSEcCtD
Saxagliptin—Immune system disorder—Topotecan—ovarian cancer	0.00102	0.00584	CcSEcCtD
Saxagliptin—Angioedema—Chlorambucil—ovarian cancer	0.00101	0.00577	CcSEcCtD
Saxagliptin—Immune system disorder—Melphalan—ovarian cancer	0.000998	0.00571	CcSEcCtD
Saxagliptin—Malnutrition—Topotecan—ovarian cancer	0.000983	0.00562	CcSEcCtD
Saxagliptin—Hypoglycaemia—Paclitaxel—ovarian cancer	0.000962	0.00551	CcSEcCtD
Saxagliptin—CYP3A5—female gonad—ovarian cancer	0.00095	0.0069	CbGeAlD
Saxagliptin—CYP3A5—vagina—ovarian cancer	0.000944	0.00686	CbGeAlD
Saxagliptin—Angioedema—Topotecan—ovarian cancer	0.000898	0.00514	CcSEcCtD
Saxagliptin—Infection—Chlorambucil—ovarian cancer	0.000895	0.00512	CcSEcCtD
Saxagliptin—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000882	0.00505	CcSEcCtD
Saxagliptin—Blood creatinine increased—Paclitaxel—ovarian cancer	0.000879	0.00503	CcSEcCtD
Saxagliptin—Immune system disorder—Vinorelbine—ovarian cancer	0.000872	0.00499	CcSEcCtD
Saxagliptin—Malnutrition—Vinorelbine—ovarian cancer	0.000841	0.00481	CcSEcCtD
Saxagliptin—Nasopharyngitis—Paclitaxel—ovarian cancer	0.000839	0.00481	CcSEcCtD
Saxagliptin—Arthralgia—Topotecan—ovarian cancer	0.000836	0.00479	CcSEcCtD
Saxagliptin—Myalgia—Topotecan—ovarian cancer	0.000836	0.00479	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000831	0.00476	CcSEcCtD
Saxagliptin—Myalgia—Melphalan—ovarian cancer	0.000819	0.00469	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000813	0.00466	CcSEcCtD
Saxagliptin—Anaphylactic shock—Topotecan—ovarian cancer	0.000802	0.00459	CcSEcCtD
Saxagliptin—Infection—Topotecan—ovarian cancer	0.000797	0.00456	CcSEcCtD
Saxagliptin—Pancreatitis—Paclitaxel—ovarian cancer	0.000795	0.00455	CcSEcCtD
Saxagliptin—ABCC1—lymph node—ovarian cancer	0.000795	0.00577	CbGeAlD
Saxagliptin—Dyspepsia—Chlorambucil—ovarian cancer	0.000793	0.00454	CcSEcCtD
Saxagliptin—Anaphylactic shock—Melphalan—ovarian cancer	0.000785	0.0045	CcSEcCtD
Saxagliptin—Thrombocytopenia—Topotecan—ovarian cancer	0.000785	0.00449	CcSEcCtD
Saxagliptin—CYP3A4—female reproductive system—ovarian cancer	0.000783	0.00569	CbGeAlD
Saxagliptin—Infection—Melphalan—ovarian cancer	0.00078	0.00447	CcSEcCtD
Saxagliptin—Skin disorder—Topotecan—ovarian cancer	0.000779	0.00446	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000778	0.00445	CcSEcCtD
Saxagliptin—Fatigue—Chlorambucil—ovarian cancer	0.000777	0.00445	CcSEcCtD
Saxagliptin—Thrombocytopenia—Melphalan—ovarian cancer	0.000769	0.0044	CcSEcCtD
Saxagliptin—Angioedema—Vinorelbine—ovarian cancer	0.000768	0.0044	CcSEcCtD
Saxagliptin—Skin disorder—Melphalan—ovarian cancer	0.000763	0.00437	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.000754	0.00432	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000737	0.00422	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000731	0.00418	CcSEcCtD
Saxagliptin—Infestation NOS—Paclitaxel—ovarian cancer	0.000723	0.00414	CcSEcCtD
Saxagliptin—Infestation—Paclitaxel—ovarian cancer	0.000723	0.00414	CcSEcCtD
Saxagliptin—Urticaria—Chlorambucil—ovarian cancer	0.000716	0.0041	CcSEcCtD
Saxagliptin—Arthralgia—Vinorelbine—ovarian cancer	0.000716	0.0041	CcSEcCtD
Saxagliptin—Myalgia—Vinorelbine—ovarian cancer	0.000716	0.0041	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000715	0.0041	CcSEcCtD
Saxagliptin—Abdominal pain—Chlorambucil—ovarian cancer	0.000712	0.00408	CcSEcCtD
Saxagliptin—Nasopharyngitis—Docetaxel—ovarian cancer	0.000712	0.00407	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000711	0.00407	CcSEcCtD
Saxagliptin—Dyspepsia—Topotecan—ovarian cancer	0.000706	0.00404	CcSEcCtD
Saxagliptin—Urinary tract infection—Paclitaxel—ovarian cancer	0.000703	0.00403	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000692	0.00396	CcSEcCtD
Saxagliptin—Fatigue—Topotecan—ovarian cancer	0.000691	0.00396	CcSEcCtD
Saxagliptin—Dyspepsia—Melphalan—ovarian cancer	0.000691	0.00396	CcSEcCtD
Saxagliptin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000686	0.00393	CcSEcCtD
Saxagliptin—Infection—Vinorelbine—ovarian cancer	0.000681	0.0039	CcSEcCtD
Saxagliptin—Sinusitis—Paclitaxel—ovarian cancer	0.000679	0.00389	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000678	0.00388	CcSEcCtD
Saxagliptin—Fatigue—Melphalan—ovarian cancer	0.000677	0.00388	CcSEcCtD
Saxagliptin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000672	0.00385	CcSEcCtD
Saxagliptin—Skin disorder—Vinorelbine—ovarian cancer	0.000666	0.00381	CcSEcCtD
Saxagliptin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000664	0.0038	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000656	0.00375	CcSEcCtD
Saxagliptin—Asthenia—Chlorambucil—ovarian cancer	0.000646	0.0037	CcSEcCtD
Saxagliptin—Oedema peripheral—Paclitaxel—ovarian cancer	0.00064	0.00366	CcSEcCtD
Saxagliptin—Pruritus—Chlorambucil—ovarian cancer	0.000637	0.00365	CcSEcCtD
Saxagliptin—Urticaria—Topotecan—ovarian cancer	0.000637	0.00365	CcSEcCtD
Saxagliptin—Abdominal pain—Topotecan—ovarian cancer	0.000634	0.00363	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000625	0.00358	CcSEcCtD
Saxagliptin—Urticaria—Melphalan—ovarian cancer	0.000624	0.00357	CcSEcCtD
Saxagliptin—Infestation—Docetaxel—ovarian cancer	0.000613	0.00351	CcSEcCtD
Saxagliptin—Infestation NOS—Docetaxel—ovarian cancer	0.000613	0.00351	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000592	0.00339	CcSEcCtD
Saxagliptin—Fatigue—Vinorelbine—ovarian cancer	0.000591	0.00339	CcSEcCtD
Saxagliptin—Hypersensitivity—Topotecan—ovarian cancer	0.000591	0.00338	CcSEcCtD
Saxagliptin—Immune system disorder—Paclitaxel—ovarian cancer	0.000587	0.00336	CcSEcCtD
Saxagliptin—Hypersensitivity—Melphalan—ovarian cancer	0.000578	0.00331	CcSEcCtD
Saxagliptin—Asthenia—Topotecan—ovarian cancer	0.000575	0.00329	CcSEcCtD
Saxagliptin—Vomiting—Chlorambucil—ovarian cancer	0.000573	0.00328	CcSEcCtD
Saxagliptin—Pruritus—Topotecan—ovarian cancer	0.000567	0.00325	CcSEcCtD
Saxagliptin—Malnutrition—Paclitaxel—ovarian cancer	0.000565	0.00324	CcSEcCtD
Saxagliptin—Asthenia—Melphalan—ovarian cancer	0.000563	0.00323	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000561	0.00321	CcSEcCtD
Saxagliptin—Flatulence—Paclitaxel—ovarian cancer	0.000557	0.00319	CcSEcCtD
Saxagliptin—Purpura—Epirubicin—ovarian cancer	0.000557	0.00319	CcSEcCtD
Saxagliptin—Pruritus—Melphalan—ovarian cancer	0.000556	0.00318	CcSEcCtD
Saxagliptin—Hypoglycaemia—Epirubicin—ovarian cancer	0.00055	0.00315	CcSEcCtD
Saxagliptin—Urticaria—Vinorelbine—ovarian cancer	0.000545	0.00312	CcSEcCtD
Saxagliptin—Abdominal pain—Vinorelbine—ovarian cancer	0.000542	0.0031	CcSEcCtD
Saxagliptin—Oedema peripheral—Docetaxel—ovarian cancer	0.000542	0.0031	CcSEcCtD
Saxagliptin—Nausea—Chlorambucil—ovarian cancer	0.000535	0.00306	CcSEcCtD
Saxagliptin—Dizziness—Topotecan—ovarian cancer	0.00053	0.00304	CcSEcCtD
Saxagliptin—Face oedema—Epirubicin—ovarian cancer	0.000518	0.00297	CcSEcCtD
Saxagliptin—Angioedema—Paclitaxel—ovarian cancer	0.000517	0.00296	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—ovarian cancer	0.000515	0.00295	CcSEcCtD
Saxagliptin—Vomiting—Topotecan—ovarian cancer	0.00051	0.00292	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000509	0.00291	CcSEcCtD
Saxagliptin—Rash—Topotecan—ovarian cancer	0.000506	0.00289	CcSEcCtD
Saxagliptin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000505	0.00289	CcSEcCtD
Saxagliptin—Dermatitis—Topotecan—ovarian cancer	0.000505	0.00289	CcSEcCtD
Saxagliptin—Blood creatinine increased—Epirubicin—ovarian cancer	0.000503	0.00288	CcSEcCtD
Saxagliptin—Headache—Topotecan—ovarian cancer	0.000502	0.00288	CcSEcCtD
Saxagliptin—Vomiting—Melphalan—ovarian cancer	0.000499	0.00286	CcSEcCtD
Saxagliptin—Immune system disorder—Docetaxel—ovarian cancer	0.000497	0.00285	CcSEcCtD
Saxagliptin—Rash—Melphalan—ovarian cancer	0.000495	0.00283	CcSEcCtD
Saxagliptin—Dermatitis—Melphalan—ovarian cancer	0.000495	0.00283	CcSEcCtD
Saxagliptin—Asthenia—Vinorelbine—ovarian cancer	0.000492	0.00282	CcSEcCtD
Saxagliptin—Pruritus—Vinorelbine—ovarian cancer	0.000485	0.00278	CcSEcCtD
Saxagliptin—Arthralgia—Paclitaxel—ovarian cancer	0.000481	0.00276	CcSEcCtD
Saxagliptin—Myalgia—Paclitaxel—ovarian cancer	0.000481	0.00276	CcSEcCtD
Saxagliptin—Nasopharyngitis—Epirubicin—ovarian cancer	0.00048	0.00275	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—ovarian cancer	0.000479	0.00274	CcSEcCtD
Saxagliptin—Malnutrition—Docetaxel—ovarian cancer	0.000479	0.00274	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000478	0.00274	CcSEcCtD
Saxagliptin—Nausea—Topotecan—ovarian cancer	0.000476	0.00273	CcSEcCtD
Saxagliptin—Gastritis—Epirubicin—ovarian cancer	0.000475	0.00272	CcSEcCtD
Saxagliptin—Nausea—Melphalan—ovarian cancer	0.000466	0.00267	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000465	0.00266	CcSEcCtD
Saxagliptin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000461	0.00264	CcSEcCtD
Saxagliptin—Infection—Paclitaxel—ovarian cancer	0.000458	0.00262	CcSEcCtD
Saxagliptin—Pancreatitis—Epirubicin—ovarian cancer	0.000455	0.0026	CcSEcCtD
Saxagliptin—Dizziness—Vinorelbine—ovarian cancer	0.000454	0.0026	CcSEcCtD
Saxagliptin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000452	0.00259	CcSEcCtD
Saxagliptin—Skin disorder—Paclitaxel—ovarian cancer	0.000448	0.00257	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000444	0.00254	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—ovarian cancer	0.000439	0.00252	CcSEcCtD
Saxagliptin—Vomiting—Vinorelbine—ovarian cancer	0.000436	0.0025	CcSEcCtD
Saxagliptin—Rash—Vinorelbine—ovarian cancer	0.000433	0.00248	CcSEcCtD
Saxagliptin—Dermatitis—Vinorelbine—ovarian cancer	0.000432	0.00247	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000431	0.00247	CcSEcCtD
Saxagliptin—Headache—Vinorelbine—ovarian cancer	0.00043	0.00246	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—ovarian cancer	0.000421	0.00241	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00042	0.00241	CcSEcCtD
Saxagliptin—Infestation—Epirubicin—ovarian cancer	0.000414	0.00237	CcSEcCtD
Saxagliptin—Infestation NOS—Epirubicin—ovarian cancer	0.000414	0.00237	CcSEcCtD
Saxagliptin—Arthralgia—Docetaxel—ovarian cancer	0.000408	0.00234	CcSEcCtD
Saxagliptin—Myalgia—Docetaxel—ovarian cancer	0.000408	0.00234	CcSEcCtD
Saxagliptin—Nausea—Vinorelbine—ovarian cancer	0.000407	0.00233	CcSEcCtD
Saxagliptin—Dyspepsia—Paclitaxel—ovarian cancer	0.000406	0.00233	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000405	0.00232	CcSEcCtD
Saxagliptin—Urinary tract infection—Epirubicin—ovarian cancer	0.000402	0.0023	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000399	0.00228	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000398	0.00228	CcSEcCtD
Saxagliptin—Fatigue—Paclitaxel—ovarian cancer	0.000398	0.00228	CcSEcCtD
Saxagliptin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000391	0.00224	CcSEcCtD
Saxagliptin—Infection—Docetaxel—ovarian cancer	0.000389	0.00222	CcSEcCtD
Saxagliptin—Sinusitis—Epirubicin—ovarian cancer	0.000388	0.00222	CcSEcCtD
Saxagliptin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000383	0.00219	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—ovarian cancer	0.000383	0.00219	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—ovarian cancer	0.000383	0.00219	CcSEcCtD
Saxagliptin—Skin disorder—Docetaxel—ovarian cancer	0.00038	0.00217	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000377	0.00216	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000372	0.00213	CcSEcCtD
Saxagliptin—Urticaria—Paclitaxel—ovarian cancer	0.000367	0.0021	CcSEcCtD
Saxagliptin—Oedema peripheral—Epirubicin—ovarian cancer	0.000366	0.00209	CcSEcCtD
Saxagliptin—Abdominal pain—Paclitaxel—ovarian cancer	0.000365	0.00209	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—ovarian cancer	0.000359	0.00206	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000356	0.00204	CcSEcCtD
Saxagliptin—Dyspepsia—Docetaxel—ovarian cancer	0.000344	0.00197	CcSEcCtD
Saxagliptin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00034	0.00195	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000338	0.00194	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000338	0.00193	CcSEcCtD
Saxagliptin—Fatigue—Docetaxel—ovarian cancer	0.000337	0.00193	CcSEcCtD
Saxagliptin—Immune system disorder—Epirubicin—ovarian cancer	0.000335	0.00192	CcSEcCtD
Saxagliptin—Asthenia—Paclitaxel—ovarian cancer	0.000331	0.0019	CcSEcCtD
Saxagliptin—Pruritus—Paclitaxel—ovarian cancer	0.000326	0.00187	CcSEcCtD
Saxagliptin—Malnutrition—Epirubicin—ovarian cancer	0.000323	0.00185	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00032	0.00183	CcSEcCtD
Saxagliptin—Flatulence—Epirubicin—ovarian cancer	0.000318	0.00182	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—ovarian cancer	0.00031	0.00178	CcSEcCtD
Saxagliptin—Abdominal pain—Docetaxel—ovarian cancer	0.000309	0.00177	CcSEcCtD
Saxagliptin—Dizziness—Paclitaxel—ovarian cancer	0.000305	0.00175	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—ovarian cancer	0.000299	0.00171	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—ovarian cancer	0.000295	0.00169	CcSEcCtD
Saxagliptin—Vomiting—Paclitaxel—ovarian cancer	0.000293	0.00168	CcSEcCtD
Saxagliptin—Rash—Paclitaxel—ovarian cancer	0.000291	0.00167	CcSEcCtD
Saxagliptin—Dermatitis—Paclitaxel—ovarian cancer	0.000291	0.00166	CcSEcCtD
Saxagliptin—Headache—Paclitaxel—ovarian cancer	0.000289	0.00165	CcSEcCtD
Saxagliptin—Hypersensitivity—Docetaxel—ovarian cancer	0.000288	0.00165	CcSEcCtD
Saxagliptin—Asthenia—Docetaxel—ovarian cancer	0.000281	0.00161	CcSEcCtD
Saxagliptin—Pruritus—Docetaxel—ovarian cancer	0.000277	0.00158	CcSEcCtD
Saxagliptin—Myalgia—Epirubicin—ovarian cancer	0.000275	0.00158	CcSEcCtD
Saxagliptin—Arthralgia—Epirubicin—ovarian cancer	0.000275	0.00158	CcSEcCtD
Saxagliptin—Nausea—Paclitaxel—ovarian cancer	0.000274	0.00157	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000273	0.00156	CcSEcCtD
Saxagliptin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000264	0.00151	CcSEcCtD
Saxagliptin—Infection—Epirubicin—ovarian cancer	0.000262	0.0015	CcSEcCtD
Saxagliptin—Dizziness—Docetaxel—ovarian cancer	0.000259	0.00148	CcSEcCtD
Saxagliptin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000258	0.00148	CcSEcCtD
Saxagliptin—Skin disorder—Epirubicin—ovarian cancer	0.000256	0.00147	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—ovarian cancer	0.000255	0.00146	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—ovarian cancer	0.000255	0.00146	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000253	0.00145	CcSEcCtD
Saxagliptin—Vomiting—Docetaxel—ovarian cancer	0.000249	0.00142	CcSEcCtD
Saxagliptin—Rash—Docetaxel—ovarian cancer	0.000247	0.00141	CcSEcCtD
Saxagliptin—Dermatitis—Docetaxel—ovarian cancer	0.000246	0.00141	CcSEcCtD
Saxagliptin—Headache—Docetaxel—ovarian cancer	0.000245	0.0014	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000244	0.0014	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—ovarian cancer	0.000242	0.00139	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00024	0.00138	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000239	0.00137	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—ovarian cancer	0.000237	0.00136	CcSEcCtD
Saxagliptin—Nausea—Docetaxel—ovarian cancer	0.000232	0.00133	CcSEcCtD
Saxagliptin—Dyspepsia—Epirubicin—ovarian cancer	0.000232	0.00133	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000228	0.0013	CcSEcCtD
Saxagliptin—Fatigue—Epirubicin—ovarian cancer	0.000227	0.0013	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000222	0.00127	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000216	0.00123	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—ovarian cancer	0.000215	0.00123	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000211	0.00121	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—ovarian cancer	0.00021	0.0012	CcSEcCtD
Saxagliptin—Urticaria—Epirubicin—ovarian cancer	0.00021	0.0012	CcSEcCtD
Saxagliptin—Abdominal pain—Epirubicin—ovarian cancer	0.000209	0.00119	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.0002	0.00114	CcSEcCtD
Saxagliptin—Hypersensitivity—Epirubicin—ovarian cancer	0.000194	0.00111	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—ovarian cancer	0.000194	0.00111	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—ovarian cancer	0.000193	0.0011	CcSEcCtD
Saxagliptin—Asthenia—Epirubicin—ovarian cancer	0.000189	0.00108	CcSEcCtD
Saxagliptin—Pruritus—Epirubicin—ovarian cancer	0.000187	0.00107	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—ovarian cancer	0.00018	0.00103	CcSEcCtD
Saxagliptin—Asthenia—Doxorubicin—ovarian cancer	0.000175	0.001	CcSEcCtD
Saxagliptin—Dizziness—Epirubicin—ovarian cancer	0.000174	0.000999	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—ovarian cancer	0.000173	0.000989	CcSEcCtD
Saxagliptin—Vomiting—Epirubicin—ovarian cancer	0.000168	0.00096	CcSEcCtD
Saxagliptin—Rash—Epirubicin—ovarian cancer	0.000166	0.000952	CcSEcCtD
Saxagliptin—Dermatitis—Epirubicin—ovarian cancer	0.000166	0.000951	CcSEcCtD
Saxagliptin—Headache—Epirubicin—ovarian cancer	0.000165	0.000946	CcSEcCtD
Saxagliptin—Dizziness—Doxorubicin—ovarian cancer	0.000161	0.000924	CcSEcCtD
Saxagliptin—Nausea—Epirubicin—ovarian cancer	0.000157	0.000897	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—ovarian cancer	0.000155	0.000888	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—ovarian cancer	0.000154	0.000881	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—ovarian cancer	0.000154	0.00088	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—ovarian cancer	0.000153	0.000875	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—ovarian cancer	0.000145	0.00083	CcSEcCtD
